Rigel Pharmaceuticals RIGL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $2.42M+8.4% | $2.23M+80.0% | $1.24M+24.0% | $998K-14.1% | ||
| $12.71M+2.6% | $12.39M+40.7% | $8.81M-28.9% | $12.39M+30.6% | ||
| $75.66M+140% | $31.47M+648% | -$5.74M+92.2% | -$73.76M— | ||
| $5M0.0% | $5M— | $0— | —— | ||
| -$92.37M— | —— | -$4.3M-106% | $72.78M+184% | ||
| —— | —— | —— | —— | ||
| —— | $0— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | $23.96M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Rigel Pharmaceuticals generate?
- Rigel Pharmaceuticals (RIGL) generated $79.3M in operating cash flow over the trailing twelve months.
- Where does Rigel Pharmaceuticals's cash flow data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
